Carina Scholtysek

2.2k total citations
29 papers, 1.4k citations indexed

About

Carina Scholtysek is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Carina Scholtysek has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Immunology. Recurrent topics in Carina Scholtysek's work include Bone Metabolism and Diseases (9 papers), Bone health and treatments (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Carina Scholtysek is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Bone health and treatments (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Carina Scholtysek collaborates with scholars based in Germany, France and United Kingdom. Carina Scholtysek's co-authors include Georg Schett, Gerhard Krönke, Stefan Uderhardt, Jörg H. W. Distler, Christian Beyer, Oliver Distler, Clara Dees, Alfiya Distler, Mario M. Zaiss and Christina Böhm and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Scientific Reports.

In The Last Decade

Carina Scholtysek

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carina Scholtysek Germany 18 730 381 208 202 191 29 1.4k
Fumitaka Mizoguchi Japan 17 577 0.8× 223 0.6× 201 1.0× 208 1.0× 144 0.8× 60 1.2k
Chih‐Yang Lin Taiwan 24 670 0.9× 197 0.5× 276 1.3× 304 1.5× 147 0.8× 58 1.4k
Tomi Häkkinen Finland 13 555 0.8× 330 0.9× 198 1.0× 155 0.8× 138 0.7× 18 1.3k
Martina Leopizzi Italy 21 763 1.0× 118 0.3× 273 1.3× 86 0.4× 89 0.5× 74 1.3k
Irene Krukovets United States 20 764 1.0× 187 0.5× 207 1.0× 64 0.3× 92 0.5× 29 1.3k
Tania Velletri Italy 12 953 1.3× 147 0.4× 381 1.8× 113 0.6× 93 0.5× 16 1.6k
Chi Sun China 20 461 0.6× 186 0.5× 194 0.9× 104 0.5× 87 0.5× 80 1.2k
Neng‐Yu Lin Germany 15 775 1.1× 225 0.6× 131 0.6× 203 1.0× 197 1.0× 40 1.2k
I‐Ping Chiang Taiwan 20 403 0.6× 122 0.3× 213 1.0× 86 0.4× 166 0.9× 55 1.1k
Lala R. Chaudhary United States 20 993 1.4× 158 0.4× 385 1.9× 246 1.2× 55 0.3× 34 2.0k

Countries citing papers authored by Carina Scholtysek

Since Specialization
Citations

This map shows the geographic impact of Carina Scholtysek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carina Scholtysek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carina Scholtysek more than expected).

Fields of papers citing papers by Carina Scholtysek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carina Scholtysek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carina Scholtysek. The network helps show where Carina Scholtysek may publish in the future.

Co-authorship network of co-authors of Carina Scholtysek

This figure shows the co-authorship network connecting the top 25 collaborators of Carina Scholtysek. A scholar is included among the top collaborators of Carina Scholtysek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carina Scholtysek. Carina Scholtysek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ledesma-Colunga, María G., Carina Scholtysek, Lorenz C. Hofbauer, et al.. (2024). Transferrin receptor 2 mitigates periodontitis‐driven alveolar bone loss. Journal of Cellular Physiology. 239(2). e31172–e31172. 4 indexed citations
3.
Taubmann, Jule, Brenda Krishnacoumar, Christina Böhm, et al.. (2020). Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis. Scientific Reports. 10(1). 47 indexed citations
4.
Stoll, Cornelia, Katrin Palumbo‐Zerr, Christina Böhm, et al.. (2020). PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass. Scientific Reports. 10(1). 8428–8428. 19 indexed citations
5.
Gelse, Kolja, Anika Grüneboom, Arnd Kleyer, et al.. (2019). Modular Lattice Constructs for Biological Joint Resurfacing. Tissue Engineering Part A. 25(13-14). 1053–1062. 3 indexed citations
6.
Scholtysek, Carina, Natacha Ipseiz, Christina Böhm, et al.. (2018). NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover. Journal of Bone and Mineral Research. 33(11). 2035–2047. 20 indexed citations
7.
Omata, Yasunori, Michael Frech, Sébastien Lucas, et al.. (2018). Group 2 Innate Lymphoid Cells Attenuate Inflammatory Arthritis and Protect from Bone Destruction in Mice. Cell Reports. 24(1). 169–180. 58 indexed citations
8.
Djouad, Farida, Natacha Ipseiz, Patricia Luz‐Crawford, et al.. (2016). PPARβ/δ: A master regulator of mesenchymal stem cell functions. Biochimie. 136. 55–58. 9 indexed citations
9.
Luz‐Crawford, Patricia, Natacha Ipseiz, Gabriel Espinosa-Carrasco, et al.. (2016). PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis. Annals of the Rheumatic Diseases. 75(12). 2166–2174. 43 indexed citations
10.
Luz‐Crawford, Patricia, Natacha Ipseiz, Andrés Caicedo, et al.. (2015). A8.24 PPARβ/δ expression orchestrates the immunosuppressive effect of mesenchymal stem cells via NF-κB signalling. Annals of the Rheumatic Diseases. 74. A91–A91. 1 indexed citations
11.
Ipseiz, Natacha, Carina Scholtysek, Stephan Culemann, & Gerhard Krönke. (2014). Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis. Swiss Medical Weekly. 144(4950). w14055–w14055. 7 indexed citations
12.
Ipseiz, Natacha, Stefan Uderhardt, Carina Scholtysek, et al.. (2014). The Nuclear Receptor Nr4a1 Mediates Anti-Inflammatory Effects of Apoptotic Cells. The Journal of Immunology. 192(10). 4852–4858. 62 indexed citations
13.
Krönke, Gerhard, Nicole Reich, Carina Scholtysek, et al.. (2012). The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. Annals of the Rheumatic Diseases. 71(6). 1081–1087. 33 indexed citations
14.
Scholtysek, Carina, Gerhard Krönke, & Georg Schett. (2012). Inflammation-Associated Changes in Bone Homeostasis. Inflammation & Allergy - Drug Targets. 11(3). 188–195. 17 indexed citations
15.
Lin, Neng‐Yu, Christian Beyer, Andreas Gießl, et al.. (2012). Autophagy regulates TNFα-mediated joint destruction in experimental arthritis. Annals of the Rheumatic Diseases. 72(5). 761–768. 223 indexed citations
16.
Böhm, Christina, Anja Derer, Roland Axmann, et al.. (2012). RSK2 protects mice against TNF-induced bone loss. Journal of Cell Science. 125(Pt 9). 2160–71. 16 indexed citations
17.
Scholtysek, Carina, Julia Katzenbeisser, Stefan Uderhardt, et al.. (2011). PPARβ regulates bone-metabolism by facilitating Wnt-signalling. Annals of the Rheumatic Diseases. 70. A90–A90. 1 indexed citations
18.
Krönke, Gerhard, Stefan Uderhardt, Kyung‐Ah Kim, et al.. (2010). R‐spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway. Arthritis & Rheumatism. 62(8). 2303–2312. 48 indexed citations
19.
Krönke, Gerhard, Julia Katzenbeisser, Stefan Uderhardt, et al.. (2009). 12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis. The Journal of Immunology. 183(5). 3383–3389. 137 indexed citations
20.
Scholtysek, Carina, et al.. (2008). Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction. Biochemical and Biophysical Research Communications. 379(3). 795–798. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026